Van ECK Associates Corp Takes $111.34 Million Position in KindlyMD, Inc. $NAKA

Van ECK Associates Corp acquired a new position in KindlyMD, Inc. (NASDAQ:NAKA) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,464,285 shares of the company’s stock, valued at approximately $111,339,000. Van ECK Associates Corp owned about 74.13% of KindlyMD at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. RK Capital Management LLC FL bought a new position in KindlyMD during the third quarter valued at about $239,052,000. Vanguard Group Inc. grew its position in KindlyMD by 32,737.0% during the 3rd quarter. Vanguard Group Inc. now owns 6,036,750 shares of the company’s stock worth $150,557,000 after acquiring an additional 6,018,366 shares during the last quarter. Correct Capital Wealth Management bought a new stake in shares of KindlyMD during the third quarter worth $111,339,000. BIT Capital GmbH bought a new position in shares of KindlyMD in the third quarter worth about $25,685,000. Finally, Fifth Lane Capital LP bought a new position in KindlyMD in the 3rd quarter worth approximately $16,710,000.

KindlyMD Price Performance

NAKA opened at $0.26 on Wednesday. The business has a fifty day simple moving average of $0.34 and a 200 day simple moving average of $1.10. KindlyMD, Inc. has a 1 year low of $0.23 and a 1 year high of $34.77. The company has a market capitalization of $113.75 million, a PE ratio of -0.23 and a beta of 31.44.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on NAKA shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of KindlyMD in a research note on Monday, December 29th. B. Riley Financial dropped their price objective on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a report on Monday, February 23rd. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, KindlyMD has an average rating of “Hold” and an average price target of $4.25.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.